News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Ahead of the Bell: Genentech, Inc. Earnings
January 15, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Biotechnology company Genentech Inc. is scheduled to report fourth-quarter and full-year financial results after the market closes Thursday, and Wall Street expects it to meet forecasts.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Genentech, Inc.
MORE ON THIS TOPIC
Podcast
Sentiment at BIO soars as FDA resets, dealmaking evolves; Amgen’s Tavneos in hot water
July 1, 2026
·
2 min read
·
Jef Akst
Business
Deep dive: Pharma CEO compensation report
June 30, 2026
·
1 min read
·
Annalee Armstrong
Layoff Tracker
BioCryst ends all internal discovery efforts
June 30, 2026
·
64 min read
·
BioSpace Editorial Staff
China
Deerfield bets up to $1.6B to snag autoimmune asset in China for Boulevard
June 30, 2026
·
1 min read
·
Annalee Armstrong
